RE:RE:RE:RE:RE:RE:vacine starting I think it's impossible for them to liquidate their position - without completely cratering the stock price - especially as they have to report their position as an insider.
they took a huge equity stake (when they didn't have to) - effectively signaling that they believe in the prospects of the company. (They gave lots of money to zenabis too, but they own very little shares at this point by comparison)
their average is effectively .41 cents on that money (not including interest/accretion debs. So they are taking a loss selling at anything less - and they seem to be long term bullish on the sector as they sprinkled money on a bunch of companies.
Ultimately - I think if beena can deliver - they can hold supreme long term for a huge return. Or - if we pitter patter - they can gain liquidity on a sale of the whole buisness (or both).
They own 33% of supreme - they have every incentive to let this rise - and support this investment.